ArticleWorld journal of gastroenterology2017

Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety.

Nyan L Latt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.